- Home
- BB vs CPRX Comparison
BB vs CPRX Comparison
Compare BB & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- CPRX
- Stock Information
- Founded
- BB 1984
- CPRX 2002
- Country
- BB Canada
- CPRX United States
- Employees
- BB N/A
- CPRX N/A
- Industry
- BB
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BB
- CPRX Health Care
- Exchange
- BB Nasdaq
- CPRX Nasdaq
- Market Cap
- BB 2.7B
- CPRX 2.6B
- IPO Year
- BB 1997
- CPRX 2006
- Fundamental
- Price
- BB $3.92
- CPRX $24.69
- Analyst Decision
- BB Buy
- CPRX Strong Buy
- Analyst Count
- BB 6
- CPRX 8
- Target Price
- BB $4.20
- CPRX $32.50
- AVG Volume (30 Days)
- BB 16.5M
- CPRX 1.5M
- Earning Date
- BB 04-02-2025
- CPRX 05-07-2025
- Dividend Yield
- BB N/A
- CPRX N/A
- EPS Growth
- BB N/A
- CPRX 107.94
- EPS
- BB N/A
- CPRX 1.31
- Revenue
- BB $638,000,000.00
- CPRX $491,734,000.00
- Revenue This Year
- BB N/A
- CPRX $15.17
- Revenue Next Year
- BB N/A
- CPRX $8.28
- P/E Ratio
- BB N/A
- CPRX $18.85
- Revenue Growth
- BB N/A
- CPRX 23.49
- 52 Week Low
- BB $2.01
- CPRX $14.47
- 52 Week High
- BB $6.24
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- BB 35.98
- CPRX 62.78
- Support Level
- BB $4.31
- CPRX $20.68
- Resistance Level
- BB $4.52
- CPRX $26.16
- Average True Range (ATR)
- BB 0.18
- CPRX 0.83
- MACD
- BB -0.05
- CPRX 0.36
- Stochastic Oscillator
- BB 5.20
- CPRX 75.21
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communication for enterprises. The firm provides endpoint management and protection to enterprises, specializing in regulated industries like government, as well as embedded software to the automotive, medical, and industrial markets.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.